Daesung Microbiological Labs. Co. Ltd (036480) — Capital Reinvestment Ratio
Daesung Microbiological Labs. Co. Ltd (036480) has a Capital Reinvestment Ratio of 0.01x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩972.26 Million) in capital expenditures (₩5.66 Million). See how leveraged is Daesung Microbiological Labs. Co. Ltd's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Daesung Microbiological Labs. Co. Ltd Capital Reinvestment Ratio (2012–2025)
This chart tracks Daesung Microbiological Labs. Co. Ltd's Capital Reinvestment Ratio across 13 annual periods. Check 036480 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Daesung Microbiological Labs. Co. Ltd (2012–2025)
Year-by-year Capital Reinvestment Ratio for Daesung Microbiological Labs. Co. Ltd from 2012 to 2025. For live market cap and broader valuation context, see 036480 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | ₩1.41 Billion | ₩358.09 Million | ▼ -32.9% |
| 2024 | 0.38x | ₩2.10 Billion | ₩795.87 Million | ▼ -81.1% |
| 2022 | 2.00x | ₩1.16 Billion | ₩2.32 Billion | ▲ +48.7% |
| 2021 | 1.35x | ₩2.20 Billion | ₩2.97 Billion | ▼ -68.9% |
| 2020 | 4.33x | ₩3.24 Billion | ₩14.01 Billion | ▼ -12.4% |
| 2019 | 4.94x | ₩2.32 Billion | ₩11.44 Billion | ▲ +3558.7% |
| 2018 | 0.14x | ₩3.14 Billion | ₩423.50 Million | ▼ -79.9% |
| 2017 | 0.67x | ₩1.68 Billion | ₩1.13 Billion | ▲ +149.5% |
| 2016 | 0.27x | ₩3.52 Billion | ₩947.87 Million | ▲ +135.8% |
| 2015 | 0.11x | ₩7.66 Billion | ₩874.96 Million | ▼ -47.2% |
| 2014 | 0.22x | ₩3.83 Billion | ₩828.54 Million | ▼ -85.8% |
| 2013 | 1.52x | ₩1.89 Billion | ₩2.88 Billion | ▲ +1599.8% |
| 2012 | 0.09x | ₩2.33 Billion | ₩209.00 Million | — |